Instructions for Authors
Kidney Research and Clinical Practice
(formerly The Korean
Journal of Nephrology
; ISSN 1975-9460, launched in 1982),
the official journal of the Korean Society of Nephrology, is an
international, peer-reviewed, open access (free submission and
free access) journal published in English. Its ISO abbreviation is
Kidney Res Clin Pract
To provide a venue for dissemination of knowledge and
discussion of topics related to basic renal science and clinical
practice, the journal considers articles on all aspects of clinical
nephrology and hypertension, as well as related molecular
genetics, anatomy, pathology, physiology, pharmacology, and
immunology. In particular, the journal focuses on translational
renal research that helps bridge laboratory discovery with the
diagnosis and treatment of human kidney disease.
Topics covered include basic science with possible clinical
applicability and papers on the pathophysiological basis of disease
processes of the kidney. Article types considered for publication
include original research, reviews on current topics of interest,
and case reports. Accepted manuscripts are granted free online
open-access immediately after publication, which permits its
users to read, download, copy, distribute, print, search, or link
to the full texts of its articles, thus facilitating access to a broad
readership. Circulation number of print copies is 1,500.
The journal is indexed in SCOPUS, ScienceDirect, DOI/Crossref,
PubMed Central (PMC), Google Scholar, KoMCI, KoreaMed, and
CAS. We are supported by the Korean Federation of Science
and Technology Societies (KOFST) Grant funded by the Korean
Government, and also by the Korean Research Foundation of
Internal Medicine (KRFIM) Grant.
1. Manuscript Submission
Manuscripts for Kidney Research and Clinical Practice should
be submitted online at http://www.krcp-ksn.org
. For editorial
questions, please contact us via e-mail (email@example.com
Articles should be prepared in the simplest form possible and
submitted in Microsoft Word (*.doc or *.docx). Manuscripts
must be typed in English and double-spaced. All pages must be
numbered consecutively starting from the title page. You may
use automatic page numbering, but do NOT use other kinds of
automatic formatting such as footnotes. Place text, references,
tables and legends in one file with each table on a new page.
Please ensure that the following submission documents are also
included, where applicable:
(1) A cover letter. It must include your name, address, telephone
and fax numbers, e-mail address, and state that all authors
have contributed to the paper and have never submitted the
manuscript, in whole or in part, to other journals.
(2) A conflict of interest disclosure statement (see relevant
(3) Articles covering the use of human samples in research and
human experiments must be approved by the relevant review
committee (see relevant section below).
(4) Articles covering the use of animals in experiments must be
approved by the relevant authorities.
(5) Articles where human subjects can be identified in descriptions,
photographs or pedigrees must be accompanied by a signed
statement of informed consent to publish (in print and online)
the descriptions, photographs and pedigrees from each subject
who can be identified (see relevant section below).
(6) Clinical trials are recommended to be registered at a primary national clinical trial registration site such as www.clinicaltrials.
, or other sites
accredited by the World Health Organization or the International
Committee of Medical Journal Editors.
(7) Where material has been reproduced from other copyrighted
sources, letter(s) of permission from the copyright holder(s) to
use the copyrighted sources must be supplied.
(8) Articles should be written in English (using American English
spelling) and meet the following basic criteria: the material is
original, the information is important, the writing is clear, concise
and grammatically correct, the study methods are appropriate,
the data are valid, and the conclusions are reasonable and
supported by the data. For non-native English-speaking authors,
we suggest that manuscripts be checked and edited by a native
2. Types of Articles
2.1. Review Articles
These describe new developments of significance in the field
of nephrology, and highlight unresolved questions and future
directions. Most reviews are solicited by the editors, but
unsolicited submissions may also be considered for publication.
Review articles should include Abstract, Introduction, brief
main headings, Conflicts of interest, and References. The text
should be limited to 5,000 words (excluding tables, figures and
2.2. Original Articles
These are expected to present major advances and important
new research results. Section headings should include Abstract,
Introduction, Methods, Results, Discussion, Conflicts of interest,
Acknowledgments (if applicable), and References. The text
should be limited to 4,000 words (excluding tables, figures and
references) and 40 references.
2.3. Case Reports
These are short peer-reviewed papers presenting novel findings in
clinical studies. Case reports are only published if they illustrate
a rare occurrence of important clinical importance. Section
headings should include Abstract, Introduction, Case, Discussion,
Conflicts of interest, and References. The text should be limited
to 1,500 words (excluding tables, figures and references) and 15
references. A maximum of 4 figures/tables may be included
2.4. Bench and Bedside
This section reviews current experimental methodologies used in
kidney research (Bench) and important diagnostic or therapeutic
techniques applied in clinical practice (Bedside). These are
usually solicited by the editors, but unsolicited submissions
may also be considered for publication. Articles should include
Abstract, Introduction, brief main headings, Conflicts of interest,
and References. The text should be limited to 4,000 words
(excluding tables, figures and references) and 30 references.
2.5. Letters to the Editor
These are letters about readers' opinions or issues of concern on
previously published articles in the journal. Receipt of letters will
not be acknowledged nor are authors generally consulted before
publication. The text should be limited to 400 words (excluding
tables, figures and references) and 5 references. Accepted letters
are subject to editing for clarity and space.
These are manuscripts that are related to materials within an issue; they raise challenging questions or explore controversies.
The editor solicits such opinion pieces. The order of the
submitted manuscript includes title page, integrated discussion,
conflict of interest, acknowledgments (if applicable) and
references. The text should be limited to 1,500 words (excluding
references) and 10 references. No figures or tables are included.
2.7 Images in practice
These present classic images of common medical conditions in
clinical nephrology. Images are an important part of much of
what we do and learn in clinical practice. The text should be
limited to 300 words. There should be no more than two figures.
No tables or references are included.
3. Manuscript Preparation
3.1. Title page
The title page should include article title, names (spelled out in
full in order of first name, initials of middle name and last name)
of all authors, and the institutions with which they are affiliated,
short running title not exceeding 50 characters, separate word
count for abstract and text, and corresponding author details
(name, address, phone, fax and e-mail information). The
individual contribution of each co-author must also be detailed.
3.2. Abstract and Keywords
Abstract should not exceed 250 words in original or review
articles and 150 words in case reports. It must be written for easy
reading with no abbreviations. The abstract of the original article
should be divided into four subsections: Background, Methods,
Results, and Conclusions. Three to five keywords should be listed
below the abstract. For selecting keywords, refer to the Index
Medicus Medical Subject Headings (Available from: http://www.
3.3. Main Text
The text for original articles, for example, should include
the following sections: Introduction, Methods, Results, and
Discussion. The Introduction should be as concise as possible,
without subheadings. The Methods section should be sufficiently
detailed. Subheadings may be used to organize the Results and
Discussion. Each section should begin on a new page.
Where a term/definition is continually referred to (≥ 3 times
in the text), it is written in full when it first appears, followed
by the subsequent abbreviation in parentheses (even if it was
previously defined in the abstract); thereafter, the abbreviation
Current standard international nomenclature for genes should be
adhered to. Genes should be typed in italic font and include the
accession number. For human genes, use genetic notation and
symbols approved by the HUGO Gene Nomenclature Committee
(http://www.genenames.org/) or refer to PubMed (https://www.
Système International (SI) units must be used, with the exception
of blood pressure values which are to be reported in mmHg.
Please use the metric system for the expression of length, area,
mass and volume.
Citing references in text
References should be cited with Arabic numerals in square
brackets. References are numbered consecutively in order of
appearance in text. Multiple references are separated by closedup
commas and ranges are indicated with en dash. References cited in tables or figure legends should be included in sequence
at the point where the table or figure is first mentioned in text.
Abstracts should not be cited unless it is the only available
reference to an important concept. Uncompleted work or work
that has not yet been accepted for publication (i.e. unpublished
observation, personal communication) should not be cited as
references. When referring to a study, if the reference has only
1 author, then list the author name directly (e.g. Hawkins 
reported that...); if the reference has 2 authors, both surnames
are listed (e.g. Hawkins and Price  reported that…); if the
reference has 3 authors or more, then list the surname of the
first author only followed by "et al" (e.g. Hawkins et al 
reported that…). Note that "et al" has not end period and is not
References are limited to those cited in text and listed in
numerical order, NOT alphabetical order. They should include,
in order, author names, article title, journal name, volume,
inclusive page numbers and year. If there is only one page, state
if the article is an abstract or letter. Names of all authors should
be listed, and should include the last name and initials of the
first name and middle name. Journal names should be in italics
and abbreviations for journal titles should conform to those
used in MEDLINE. If citing a website, author information, article
title, website address and the date the site was accessed should
be provided. For an article in press, the journal name and, if
possible, the volume and year, must be provided.
Note the use of italics, semi-colons, colons, en dashes, word
capitalization, and page range.
Su DH, Chang YC, Chang CC: Post-traumatic anterior and posterior
pituitary dysfunction. J Formos Med Assoc 104:463–467, 1982
Macdougall IC: Evolution of iviron compounds over the last
century. J Ren Care 35 (Suppl 2): S8–S13, 2009
Park CH, Kim EH, Roh YH, Kim HY, Lee SK: The association
between the use of proton pump inhibitors and the risk of
hypomagnesemia: a systematic review and meta-analysis. PLoS
One 9:e112558, 2014
Book with edition:
Plum F, Posner JB: The Diagnosis of Stupor and Coma, 3rd edition.
Philadelphia: FA Davis, 123–133, 1980
Book chapter in book with editors:
Kurland LT: The epidemiologic characteristics of multiple
sclerosis. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical
Neurology, Vol 9: Multiple Sclerosis and Other Demyelinating
Diseases. Amsterdam: North-Holland Publishing, 63–84, 1970
Book chapter in book with editors and edition:
Levinsky NG: Fluid and electrolytes. In: Thorn GW, Adams RD,
Braunwald E, et al, eds. Harrison's Principles of Internal Medicine,
8th edition. New York: McGraw-Hill, 364–375, 1977
Adams JH: Central pontine myelinolysis. In: Proceedings of the
4th International Congress of Neuropathology, 1961, Munich, Vol 3.
Stuttgart: Thieme, 303–308, 1962 [Abstract]
Hung TP, Chiang TR. Multiple sclerosis in Taiwan: clinical,
electrophysiological and epidemiological studies. In: 6th Asian
and Oceanian Congress of Neurology, 1983, Taipei. Asia Pacific
Congress Series No 22. Hong Kong: Excerpta Medica, 28, 1983
Cairns RB: Infrared Spectroscopic Studies of Solid Oxygen.
Berkeley, California: University of California, 156, 1965
HIV/AIDS Reports 2007. Available at: http://www.cdc.gov.tw/
Download%20HIVAIDS%20Data. htm [Date accessed: 31
Eastman Kodak Company, Eastman Organic Chemicals. Catalog
No. 49. Rochester, NY: Eastman Kodak, 2−3, 1977
General acknowledgments for consultations, statistical analysis
and so on should be listed after main body of text, before the
References section, including the names of the individuals
involved. All financial and material support for the research and
the work should be stated here clearly explicitly.
Tables are numbered consecutively using Arabic numerals in the
order of their citation in text. Tables should be typed doublespaced
on separate pages in as simple a form as possible. Table
titles should be short and descriptive (e.g. Table 1. Demographic
characteristics of patients). Information requiring extra
explanaztory footnotes should be denoted using these symbols
(in order of appearance): *, †, ‡, §, ||, ¶, #, **, ††, ‡‡
. When there are
more than 10 footnotes, use superscript lowercase letters.
Abbreviations used in the table must be defined and placed after
the footnotes as shown here: CT, computed tomography; MRI,
magnetic resonance imaging. Certain words can be abbreviated
in tables as follows: years to yr, months to mo, days to d, hours
to hr, minutes to min, seconds to sec, and to &. Use en dash for
Figure legends should be submitted for all figures. They should
be brief and specific, and placed on a separate sheet after the
References section. Figures are numbered consecutively using
Arabic numerals in the order of their citation in the text. Figures
should be uploaded as separate files, not embedded in the
manuscript file. Figures that are line drawing or photographs
must be submitted separately in high-resolution EPS or TIFF
format (or alternatively in high-resolution JPEG format). Please
ensure that files are supplied at the correct resolution (1,200 dpi
for line drawings and 600 dpi for images such as gels or blots,
and 300 dpi for color and half-tone artwork). The files are to be
named according to the figure number and format (e.g. Fig1.tif).
Figures that are reproduced from other published sources require
written permission from the authors and copyright holders. The
first color figure charges $600, and $100 of each additional one.
Authors must bear all costs associated with printed color figures.
If authors elect not to print in color, in most cases, authors will
be able to have their color figures produced in black and white
for the printed version of the journals, but the figures will appear
in color online.
3.8. Supplemental digital content
Authors can submit Supplementary digital content to supplement
the information provided in the print version of the manuscript.
Supplementary materials will be published online-only. When
uploading Supplementary files through the online system, please
use the "Supplementary" file designation. Supplementary
materials must be cited consecutively in the main body of the
submitted manuscript and include the type of material submitted
(e.g., "Suppl. Table 1"; "Suppl. Fig. 1").
4. Ethical Considerations
4.1. Ethical Approval of Studies
For human or animal experimental investigations, appropriate
institutional review board or ethics committee approval is
required. Such approval should be stated in the Methods section
of the manuscript. For those investigators who do not have
formal ethics review committees, the principles outlined in
the Declaration of Helsinki should be followed (World Medical
Association. Declaration of Helsinki: Ethical principles for medical
research involving human subjects. Available at: http://www.
4.2. Conflicts of Interest
The corresponding author must inform the editor of any
potential conflicts of interest that could influence the authors'
interpretation of the data. Examples of potential conflicts
of interest include financial support from or connections to
pharmaceutical companies, political pressure from interest
groups, and academically related issues. Conflict of interest
statements will be published at the end of the text of the article,
before the References section. Please consult the Committee on
Publishing Ethics guidelines (http://www.publicationethics.org/
on conflict of interest.
Authorship credit should be based on 1) conception or design,
or analysis and interpretation of data; 2) drafting the article or
revising it; 3) providing intellectual content of critical importance
to the work described; and 4) final approval of the version to be
published. Authors should meet above four conditions.
4.4. Redundant Publication or Duplicate Submission
Redundant (or duplicate) publication is publication of a paper
that overlaps substantially with one already published in print
or electronic media. Submitted manuscripts are considered with
the understanding that they have not been published previously
in print or electronic format (except in abstract or poster form)
and are not under consideration in totality or in part by another
publication or electronic medium. For more information, please
refer to Uniform Requirements for Manuscripts Submitted
to Biomedical Journals: Writing and Editing for Biomedical
Publication (Available at: http://www.icmje.org/2006_urm.pdf
5. Review Process
All submissions are sent to peer reviewers. Authors will usually
be notified within 4 weeks by e-mail of whether the submitted
article is accepted for publication, rejected, or subject to
revision before publication. Revised manuscripts must be
submitted online by the corresponding author. Failure to resubmit
the revised manuscript within 6 months of the editorial decision
is regarded as a withdrawal.
6. Peer review
This journal operates a double blind review process. All
contributions will be initially assessed by the editor for suitability
for the journal. Papers deemed suitable are then sent to a
minimum of two independent expert reviewers to assess the
scientific quality of the paper. The Editor is responsible for the
final decision regarding acceptance or rejection of articles. The
Editor's decision is final.
Additional professional reprints (which include a cover page
for the article) may be ordered at prices based on the cost of
production. A reprint order form is provided by the Publisher,
together with the galley proofs.
Kidney Research and Clinical Practice is the official peer-reviewed
publication of the Korean Society of Nephrology. Manuscripts
published in the Journal become the permanent property the
Korean Society of Nephrology. All articles published in the Journal
are protected by copyright, which covers the exclusive rights
to reproduce and distribute the article, as well as translation
rights. No KRCP article, in part or whole, may be reproduced,
stored in any retrieval system, or transmitted in any form or by
any means, electronic, mechanical, by photocopying, recording,
or otherwise, without prior written permission from the Korean
Society of Nephrology.
9. Similarity Check
Similarity Check is a multi-publisher initiative to screen published
and submitted content for originality. To find out more about Similarity Check, visit http://www.crossref.org/crosscheck/index.html.
All manuscripts submitted to Kidney Research and
Clinical Practice may be screened, using the iThenticate tool, for
textual similarity to other previously published works.
10. Open access
Every peer-reviewed research article appearing in this journal
will be published open access. This means that the article is
universally and freely accessible via the internet in perpetuity,
in an easily readable format immediately after publication. The
author does not have any publication charges for open access.
The Korean Society of Nephrology will pay to make the article
open access. All articles will be published under the following
Creative Commons Attribution-NonCommercial-NoDerivs (CC
for non-commercial purposes, lets others distribute
and copy the article, and to include in a collective work (such as
an anthology), as long as they credit the author(s) and provided
they do not alter or modify the article.